BSc(Hons) (Applied Mathematics), PhD
Amy completed her PhD in 2014 at the Kirby Institute with David Wilson modelling HIV and hepatitis C among PWID in Australia and HIV among at-risk groups in Indonesia. Her work focused on using models to understand the epidemiology of HIV and hepatitis C among these populations as well as assessing the cost-effectiveness of prevention programs. This work contributed substantially to the “Return on investment 2: Evaluating the cost-effectiveness of needle and syringe programs in Australia” report. In 2016 Amy returned to the Kirby Institute, joining SERP to initially assist with data synthesis and analysis for the BRISE HCV and HBV estimates and projections projects. Amy also works with VHEPP to assess needle and syringe distribution coverage.
HIV, HCV, HBV, AIDS, BBVs, Antiretroviral therapy, Australia, Asia, Indonesia, Mathematical modelling, Cost-effectiveness analysis, PWID, NSP, Infectious disease, Epidemiology, Public Health, Prevalence, Incidence